Literature DB >> 6281166

Fiber counting and analysis in the diagnosis of asbestos-related disease.

A Churg.   

Abstract

Analysis of numbers and types of asbestos fibers present in lung tissue may provide insights into the pathogenesis of asbestos-induced disease, as well as diagnostic information concerning the relationship of a given lesion to asbestos exposure. This type of analysis requires extraction of fibers and asbestos bodies from lung tissue, preferably by means of a digestion-and-concentration technique, and examination with a combination of electron optical techniques, including electron diffraction and energy-dispersive x-ray spectroscopy. The combination permits definitive identification of asbestos fibers. Asbestos bodies have been shown to contain asbestos no matter what population they are found in, but they appear to be of value in ascertaining unusual exposure only when present in very large numbers. Numbers of asbestos bodies markedly underestimate total numbers of fibers present in lung. In patients from the general population, the mean number of asbestos fibers is about 1 X 10(6)/g dry lung; of this number, more than 80 per cent are fibers of chrysotile less than 5 microns long. Patients in the general population who have pleural plaques have about the same total number of fibers, but their lungs contain about a 50-fold increase in long thin amphibole fibers of commercial origin. Patients who have asbestosis and most patients who have mesothelioma have 100 to 200 X 10(6) fibers/g dry lung; the grade of asbestosis appears to be related to total fiber content. Occasional patients may develop mesotheliomas with much smaller fiber burdens. Both benign and malignant pleural diseases appear to be closely related to the presence of long thin amphibole fibers. Analysis of pulmonary fiber burden suggest that asbestos-related disease is not merely a matter of total numbers of fibers present, but that factors such as fiber type and size are equally important.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6281166     DOI: 10.1016/s0046-8177(82)80227-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Fibre distribution in the lungs and pleura of subjects with asbestos related diffuse pleural fibrosis.

Authors:  A R Gibbs; M Stephens; D M Griffiths; B J Blight; F D Pooley
Journal:  Br J Ind Med       Date:  1991-11

Review 2.  Analysis and interpretation of inorganic mineral particles in "lung" tissues.

Authors:  A R Gibbs; F D Pooley
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

Review 3.  Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.

Authors:  A Herbert
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

4.  Substantiating hazardous exposure to asbestos by examination of pulmonary dust.

Authors:  F Eitner
Journal:  Int Arch Occup Environ Health       Date:  1988       Impact factor: 3.015

Review 5.  Mesothelioma: cases associated with non-occupational and low dose exposures.

Authors:  G Hillerdal
Journal:  Occup Environ Med       Date:  1999-08       Impact factor: 4.402

6.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

7.  Correlation between fibre content of the lung and disease in east London asbestos factory workers.

Authors:  J C Wagner; M L Newhouse; B Corrin; C E Rossiter; D M Griffiths
Journal:  Br J Ind Med       Date:  1988-05

8.  Asbestos induced diffuse pleural fibrosis: pathology and mineralogy.

Authors:  M Stephens; A R Gibbs; F D Pooley; J C Wagner
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

9.  Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings.

Authors:  Atsushi Kagimoto; Takeshi Mimura; Atsushi Kamigaichi; Yoshinori Yamashita
Journal:  BMC Cancer       Date:  2022-04-28       Impact factor: 4.638

10.  An unusual case of mixed-dust exposure involving a "noncommercial" asbestos.

Authors:  R F Dodson; J L Levin
Journal:  Environ Health Perspect       Date:  2001-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.